ORIGINAL ARTICLE

High serum interleukin-2 levels are associated with pruritus in chronic kidney disease undergoing regular hemodialysis

Luh Made Mas Rusyati , Yenny Kandarin, Ni Nyoman Tri Priliawati

Luh Made Mas Rusyati
Dermatology and Venereology Department, Faculty of Medicine, Universitas Udayana-Sanglah General Hospital, Bali-Indonesia. Email: rusyati@unud.ac.id

Yenny Kandarin
Internal Medicine Department, Faculty of Medicine, Universitas Udayana-Sanglah General Hospital, Denpasar, Bali-Indonesia

Ni Nyoman Tri Priliawati
Dermatology and Venereology Department, Faculty of Medicine, Universitas Udayana-Sanglah General Hospital, Bali-Indonesia
Online First: October 20, 2020 | Cite this Article
Rusyati, L., Kandarin, Y., Priliawati, N. 2020. High serum interleukin-2 levels are associated with pruritus in chronic kidney disease undergoing regular hemodialysis. Bali Medical Journal 9(3): 565-568. DOI:10.15562/bmj.v9i3.2018


Background: Uremic pruritus or more accurately termed ‘chronic kidney disease-associated pruritus’ (CKD-aP) is chronic itch in patients with advanced or end-stage renal disease without evidence of any other active disease that could explain the pruritus. The pathogenesis of CKD-aP is complex and not fully clarified. Some preliminary studies indicate that CKD-aP is a systemic inflammatory disease with a deranged balance of T helper (TH) cell differentiation toward TH1 predominance especially IL-2. This study aimed to elucidate further the association of interleukin-2 serum levels with CKD-aP in patients undergoing regular hemodialysis (HD).

Methods: This was an analytical cross-sectional study. Sampling was taken with consecutive sampling technique. This study was carried out on 72 patients on regular HD consist of 36 patients with CKD-aP and 36 patients without CKD-aP after meeting the inclusion and exclusion criteria. Blood samples were obtained at Hemodialysis Unit Sanglah General Hospital and IL-2 serum levels were measured at Clinical Pathology Laboratory Sanglah General Hospital Denpasar between July 2019 and August 2019. Mann-Whitney U Test was used to compare IL-2 serum between CKD-aP and non-CKD-aP group.

Results: Results in this study we found higher median IL-2 level (17.1 ng/l) on pruritus group versus those without pruritus (13 ng/mL) (p<0.05).

Conclusion: IL-2 serum levels on CKD-aP patients are higher than those without CKD-aP in patients who undergo regular hemodialysis.

References

Layegh P, Mojahedi MJ, Malekshah PE, et al. Effect of oral granisetron in uremic pruritus. Indian J Dermatol Venereol Leprol. 2007;73(4):231–234.

Swarna SS, Aziz K, Zubair T, Qadir N, Khan M. Pruritus Associated With Chronic Kidney Disease: A Comprehensive Literature Review. Cureus. 2019;28;11(7):e5256.

Thakur A, Chaundhari S, Chaundari P, Thakur M. Phototherapy as a treatment for uremic pruritus-a review. General Medicine: open acess. 2015;3:1-7.

Ozen N, Cinar FI, Askin D, Mut D. Uremic pruritus and associated factors in hemodialysis patients: A multi-center study. Kidney Res Clin Pract. 2018;37(2):138-147.

Fallahzadeh MK, Roozbeh J, Geramizadeh B, Namazi MR. Interleukin-2 serum levels are elevayed in patients with uremic pruritus: a novel finding with practical implication. Nephrol Dial Transplant. 2011;26:3338-3344.

Azim AA, Farag AS, El-Maleek Hassan DA, Abdu SI, Lashin SA, Abdelaziz NM. 2015. Role of interleukin-2 in uremic pruritus among attendants of Al-Zahraa hospital dialysis unit. Indian J Dermatol ;60:211.

Yosipovitch G, Bernhard J.D. Clinical practice. Chronic pruritus. N Engl J Med. 2013;368:1625–1634

Wahlgren C, Hägermark Ö, Linder MT.Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects. Arch Dermatol Res. 1995;287:572–580.

Darsow U, Ring J, Scharein E, Bromm B. Correlations between histamine-induced wheal, flare and itch. Arch Dermatol Res. 1996;288:436–441.

Gaspari AA, Lotze MT, Rosenberg SA, Stern JB, Katz SI. Dermatologic Changes Associated With Interleukin 2 Administration. JAMA. 1987;258(12):1624–1629.

Nakamura M, Toyoda M, Morohashi M. Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors. Br J Dermatol. 2003;149(4):718-30.

Hanisch UK, Quirion R. Interleukin-2 as a neuroregulatory cytokine. Brain Res Brain Res Rev. 1995;21(3):246-84.

Ikoma A, Steinhoff M, Stander S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nature Reviews. 2006;7:535-547.

Lee JS, Han JS, Lee K, Bang J, Lee H. The peripheral and central mechanisms underlying itch. BMB Rep. 2016;49(9):474-87.

Cote-Sierra J, Foucras G, Guo L, Chiodetti L, Young HA, Hu-Li J, Zhu J, Paul WE. Interleukin 2 plays a central role in Th2 differentiation. Proc Natl Acad Sci U S A. 2004;16;101(11):3880-5.

Fang D, Elly C, Gao B, Fang N, Altman Y, Joazeiro C, Hunter T, Copeland N, Jenkins N, Liu YC. Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation. Nat Immunol. 2002;3(3):281-7.

Singer BD, D'Alessio FR. Regulatory T cell Itch reins in Th2 inflammation. Cell Mol Immunol. 2014;11(2):126-8.


No Supplementary Material available for this article.
Article Views      : 0
PDF Downloads : 0